The slowdown may be temporary, but the situation could become much more concerning the longer owners defer selling their businesses, per DeVoe & Co.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
There are a number of things to consider, including the fate of the products investors love, when their issuer is acquired.
The dollar figures in RIA M&A transactions are eye-popping, but that’s only part of the story.
The acquisition would more than double the firm’s fixed income ETF assets.
The deal gives Eli Lilly access to a psychedelic-based nasal spray that studies show curbs treatment-resistant depression in a single dose.
The US men’s national soccer team’s World Cup performance is likely to have significant impact on broadcasters and high-flying investors.
Merck KGaA’s agreement to buy Bio-Techne for $11.3 billion strengthens its hold in life sciences, especially drug discovery and gene therapy.
Acquirers want firms with strong organic growth and next-generation leaders in place.
Most of the opportunities lie with the biggest firms, which have the deepest pockets, but Cerulli sees mergers up and down the AUM spectrum.
The issue isn’t the number. It’s the lens being used to arrive at it.
Bolloré Group, which holds 40% voting rights in Universal Music, has given a thumbs-down to a $65 billion takeover bid.
GameStop CEO Ryan Cohen is sidestepping questions about how much a proposed takeover of eBay — for $56 billion — would benefit stockholders.
The year’s mergers and acquisitions are off to the fastest start ever, and the size of firms being bought is trending upward.
The key patent protections on Keytruda, Merck’s immunotherapy treatment that outsold all other prescription drugs last year, ends in 2028.
A record year for deals highlights the succession challenges RIAs are struggling to overcome.
Standout deals included Union Pacific’s $88 billion purchase of Norfolk Southern and the $56.6 billion deal to take Electronic Arts private.